Please upgrade your Flash Player
Latest Update: Monday, October, 13th 2008
Urges and requests the Louisiana Board of Pharmacy to convene its Regulation Revision Committee to consider changes to the rules and regulations of the board to expressly prohibit a pharmacist from interchanging an antiepileptic drug for the treatment of epilepsy without the prior notification of both the prescribing physician and the patient
Latest Actions- 06/11/2008 - Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
- 06/10/2008 - HCR198: Signed by the President of the Senate.
- 06/10/2008 - HCR198: Enrolled and signed by the Speaker of the House.
- 06/09/2008 - HCR198: Received from the Senate without amendments.
- 06/09/2008 - HCR198: Received in the Senate. Rules suspended, read by title and concurred in by the vote of 30 yeas and 0 nays and ordered to the House.
show all actions- 06/11/2008 - Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
- 06/10/2008 - HCR198: Signed by the President of the Senate.
- 06/10/2008 - HCR198: Enrolled and signed by the Speaker of the House.
- 06/09/2008 - HCR198: Received from the Senate without amendments.
- 06/09/2008 - HCR198: Received in the Senate. Rules suspended, read by title and concurred in by the vote of 30 yeas and 0 nays and ordered to the House.
- 06/05/2008 - HCR198: Read by title, rules suspended, adopted, ordered to the Senate.
show latest actions |
